Important National

Collaboration

GLOBAL and the National Down Syndrome Congress signed an important multi-year agreement that will increase research and medical care education and outreach to people with Down syndrome and their families. The agreement builds on 12 years of collaboration and includes the GLOBAL Research & Medical Care Roundtable at the NDSC Annual Convention which has become a must-attend free benefit for convention attendees.

Local news highlights Jordan Stewart finding a job in advertising after graduating from the first class of the GLOBAL Inclusive Program at Regis University this year. 

Groundbreaking Crnic Institute study in Cell Reports reveals signs of lower oxygen availability and dysregulated red blood cell function in people with Down syndrome pointing to new target for intervention.

Crnic Institute first in-kind clinical trial initial results published in eLIFE shows JAK Inhibitor improves autoimmune conditions including alopecia areata and psoriasis in patients with Down syndrome.

Breakthrough Crnic Institute study published in Nature Communications identifies three molecular subtypes of Down syndrome that could lead to personalized treatments and improved understanding of co-occurring conditions.